SynthesisJournal of robotic surgery2025
To investigate the current evidence in post-operative outcomes to support the use of robotic-assisted laparoscopic (radical) prostatectomy (RALP) over laparoscopic radical prostatectomy (LRP) in cases of organ-confined prostate cancer.
Synthesis in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate the current evidence in post-operative outcomes to support the use of Robotic-Assisted Laparoscopic (radical) Prostatectomy (RALP) over Laparoscopic Radical Prostatectomy (LRP) in cases of organ-confined prostate cancer. A systematic review was performed according to PRISMA/MOOSE guidelines. Dichotomous variables were pooled as risk ratios (RR). Continuous variables were pooled as weighted mean differences (WMD). Quality assessment was performed using the Newcastle-Ottawa score (NOS). Four suitable randomised controlled studies were identified from the literature. 1026 male patients with prostate cancer (LRP n = 342, 33.33%; RALP n = 684, 66.67%) were identified as eligible for inclusion. These patients were randomised for definitive operative management to RALP or LRP. There was no statistically significant difference identified in operative time (MD -2.81, 95% CI -12.92-7.31, I
Indexed as
Identifiers
41272332What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.